INDUSTRY NEWS

CE CERTIFICATE

Oertli Instrumente AG has obtained the CE certificate for its new OS4® surgical platform for vitreoretinal, cataract and glaucoma surgery. The company says the unique HDC control (High Definition Dynamic Direct Control) responsible for perfectly uniting the system with the micro-motoric movements of the surgeon is particularly impressive. 
“Thanks to HDC control, the OS4® with its instruments acts as an extension of the surgeon’s hand by carrying out commands and intentions with the same degree of perfection as the surgeon’s own hand, resulting in highest resolution, dynamic, direct and instant performance,” said a company spokeswoman.

www.oertli-os4.com

NEW APPLICATION TECHNOLOGIES 
LENSAR has received the CE Mark from European Union regulators for a suite of five new application technologies integrated into the company’s flagship product, the LENSAR® Laser System. 
“This important approval, following so rapidly on the heels of our US FDA clearance, is further evidence of LENSAR’s ongoing commitment to speeding innovation to the global market,” said LENSAR CEO Nicholas T Curtis.

www.lensar.com

NICE GUIDANCE WELCOMED
Allergan plc has welcomed the publication of NICE guidance recommending the use of OZURDEX® (dexamethasone 0.7mg intravitreal implant in applicator) for an important group of patients with diabetic macular oedema (DME). 
“This guidance from NICE confirms the value of OZURDEX® as a treatment for DME, and supports its use as a clinically relevant and cost effective option for patients with this condition,” said Sara Vincent, Senior Vice President and Allergan UK Country Manager.

www.allergan.com